Thermo Fisher Scientific Inc. Share Price Deutsche Boerse AG
Equities
TN80
CA88355G1000
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
14.3 EUR | +0.70% | +2.90% | 0.00% |
05-10 | UK Competition Regulator Opens Probe on Thermo Fisher, Olink Merger | MT |
05-10 | UK Competition Watchdog Opens Probe on Thermo Fisher Scientific's Acquisition of Olink | MT |
Sales 2024 * | 43.01B 39.72B 3,415B | Sales 2025 * | 46.08B 42.55B 3,659B | Capitalization | 227B 210B 18,030B |
---|---|---|---|---|---|
Net income 2024 * | 6.11B 5.64B 485B | Net income 2025 * | 7B 6.47B 556B | EV / Sales 2024 * | 5.84 x |
Net Debt 2024 * | 23.99B 22.16B 1,905B | Net Debt 2025 * | 19.18B 17.72B 1,523B | EV / Sales 2025 * | 5.34 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific Inc.
1 day | -0.70% | ||
1 week | +2.90% | ||
Current month | +1.43% | ||
1 month | +0.71% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
Director of Finance/CFO | 57 | 31/05/01 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 31/10/01 |
C. Harris
BRD | Director/Board Member | 67 | 29/03/12 |
Ruby Chandy
BRD | Director/Board Member | 62 | 28/02/22 |
Date | Price | Change |
---|---|---|
15/05/24 | 14.3 | +0.70% |
14/05/24 | 14.2 | -0.70% |
13/05/24 | 14.3 | -8.33% |
10/05/24 | 15.6 | +12.23% |
09/05/24 | 13.9 | +0.72% |
Delayed Quote Deutsche Boerse AG, May 15, 2024 at 08:15 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.07% | 192B | |
+13.88% | 136B | |
+27.12% | 108B | |
+0.91% | 64.07B | |
+6.74% | 51.87B | |
+13.39% | 52.1B | |
+8.81% | 44.33B | |
+4.14% | 36.75B | |
+25.48% | 31.71B |
- Stock Market
- Equities
- TMO Stock
- TN80 Stock